Media relations
HOME>Company>Media relations
Taejoon Pharm. to Sponsor 2015 “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Servi
2017.01.24 | 김미희
- ‘Best Thesis Award’ given to army doctor Seongjun An at the Armed Forces Capital Hospital
- ‘Taejoon Ophthalmology Service Award’ given to Byeongro Seo, director of Suwon Seo Eye Center
- ‘Excellent Thesis Award’ given to Prof. Jinhyeong Kim at Inje University College of Medicine
- ‘Resident Thesis Award’ given to clinical instructor Yongwu Ji at Yonsei University College of Medicine
- ‘Most Highly-Cited KJO Thesis Award’ given to Prof. Mincheol Shin at Hallym University College of Medicine and Prof. Migeum Kim at Seoul National University College of Medicine
The awards ceremony for 14th “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Service Award” sponsored by Taejoon Pharm. (President Taeyoung Lee, CEO Joon youb Lee) was held at the 114th symposium of the Korean Ophthalmological Society at KINTEX from 6th-8th of Nov.
2015 Taejoon Ophthalmology Best Thesis Award went to army doctor Seongjun An at the Armed Forces Capital Hospital and Taejoon Ophthalmology Service Award to Byeongro Seo, director of Suwon Seo Eye Center. Prof. Jinhyeong Kim at Inje University College of Medicine and clinical instructor Yongwu Ji at Yonsei University College of Medicine were honored with Excellent Thesis Award and Resident Thesis Award, respectively. Prof. Mincheol Shin at Hallym University College of Medicine and Prof. Migeum Kim at Seoul National University College of Medicine were the co-winners of this year’s newly-created Most Highly-Cited KJO Thesis Award.
Starting from 2002, “Taejoon Ophthalmology Thesis Award” has been given to healthcare providers who have contributed to the development of ophthalmology in Korea for the last 14 years. The prize money for Best Thesis Award and Service Award is 5 million won and 3 million won for Excellent Thesis award and Resident Thesis Award and 1 million won for Most Highly-Cited KJO Thesis Award. During this academic conference period, two symposiums were held by Taejoon Pharm. for the participant eye specialists.
On Nov. 7, Prof. Gyeongcheol Yun from Jeonnam University College of Medicine gave a presentation on “The Characteristics and Selection of Various Hyaluronic Acid Eye Drops” and on the next day, Prof. Hiroshi Fujishima from Tsurumi University received a very positive response from the participants through his presentation on “How Should we use NSAID(Nonsteroidal Anti-Inflammatory Drug)?”
As an innovative pharmaceutical company designated by the Ministry of Health and Welfare, Taejoon Pharm. took this academic conference as an opportunity to publicize the excellence of their various ophthalmic products by setting up promotion booths for introducing to the participants “New Hyalyuni Eye Drops 0.15% (0.35mL),” the first medication for dry eyes in Korea to contain 0.15% Sodium Hyaluronate; “Xalost Eye Drops” for the treatment of open angle glaucoma, which is exported to Europe; “Cyclosporine,” a nano-emulsion that quickly relieves dry eye symptoms; “OCUAREDSTU M” effective for preventing and treating macular degeneration; “Gatiflo Antibiotic Eye Drops,” a 4G antibiotic eye drop with low-level corneal toxicity; NSAID’s “Bronuck,” the No.1 prescription in Korea, USA, and Japan, which has a powerful anti-inflammatory and pain-reliving effect; and other products.
Supplying excellent medical products manufactured using its facilities that gained Korea’s first EU-GMP certification in 2008, Taejoon Pharm. is continuing to support the development of ophthalmology in Korea through Taejoon Workshop Funds and Taejoon Ophthalmology Thesis Award, Service Award, and at the same time serving Koreans’ eye health by conducting various social contribution activities together with Korean Foundation for the Prevention of Blindness.
From left, Mansu Kim, director of the Korean Ophthalmological Society, Byeongro Seo, director of Suwon Seo Eye Center, and Taeyoung Lee, president of Taejoon Pharm.
- ‘Best Thesis Award’ given to army doctor Seongjun An at the Armed Forces Capital Hospital
- ‘Taejoon Ophthalmology Service Award’ given to Byeongro Seo, director of Suwon Seo Eye Center
- ‘Excellent Thesis Award’ given to Prof. Jinhyeong Kim at Inje University College of Medicine
- ‘Resident Thesis Award’ given to clinical instructor Yongwu Ji at Yonsei University College of Medicine
- ‘Most Highly-Cited KJO Thesis Award’ given to Prof. Mincheol Shin at Hallym University College of Medicine and Prof. Migeum Kim at Seoul National University College of Medicine
The awards ceremony for 14th “Taejoon Ophthalmology Thesis Award” and “Taejoon Ophthalmology Service Award” sponsored by Taejoon Pharm. (President Taeyoung Lee, CEO Joon youb Lee) was held at the 114th symposium of the Korean Ophthalmological Society at KINTEX from 6th-8th of Nov.
2015 Taejoon Ophthalmology Best Thesis Award went to army doctor Seongjun An at the Armed Forces Capital Hospital and Taejoon Ophthalmology Service Award to Byeongro Seo, director of Suwon Seo Eye Center. Prof. Jinhyeong Kim at Inje University College of Medicine and clinical instructor Yongwu Ji at Yonsei University College of Medicine were honored with Excellent Thesis Award and Resident Thesis Award, respectively. Prof. Mincheol Shin at Hallym University College of Medicine and Prof. Migeum Kim at Seoul National University College of Medicine were the co-winners of this year’s newly-created Most Highly-Cited KJO Thesis Award.
Starting from 2002, “Taejoon Ophthalmology Thesis Award” has been given to healthcare providers who have contributed to the development of ophthalmology in Korea for the last 14 years. The prize money for Best Thesis Award and Service Award is 5 million won and 3 million won for Excellent Thesis award and Resident Thesis Award and 1 million won for Most Highly-Cited KJO Thesis Award. During this academic conference period, two symposiums were held by Taejoon Pharm. for the participant eye specialists.
On Nov. 7, Prof. Gyeongcheol Yun from Jeonnam University College of Medicine gave a presentation on “The Characteristics and Selection of Various Hyaluronic Acid Eye Drops” and on the next day, Prof. Hiroshi Fujishima from Tsurumi University received a very positive response from the participants through his presentation on “How Should we use NSAID(Nonsteroidal Anti-Inflammatory Drug)?”
As an innovative pharmaceutical company designated by the Ministry of Health and Welfare, Taejoon Pharm. took this academic conference as an opportunity to publicize the excellence of their various ophthalmic products by setting up promotion booths for introducing to the participants “New Hyalyuni Eye Drops 0.15% (0.35mL),” the first medication for dry eyes in Korea to contain 0.15% Sodium Hyaluronate; “Xalost Eye Drops” for the treatment of open angle glaucoma, which is exported to Europe; “Cyclosporine,” a nano-emulsion that quickly relieves dry eye symptoms; “OCUAREDSTU M” effective for preventing and treating macular degeneration; “Gatiflo Antibiotic Eye Drops,” a 4G antibiotic eye drop with low-level corneal toxicity; NSAID’s “Bronuck,” the No.1 prescription in Korea, USA, and Japan, which has a powerful anti-inflammatory and pain-reliving effect; and other products.
Supplying excellent medical products manufactured using its facilities that gained Korea’s first EU-GMP certification in 2008, Taejoon Pharm. is continuing to support the development of ophthalmology in Korea through Taejoon Workshop Funds and Taejoon Ophthalmology Thesis Award, Service Award, and at the same time serving Koreans’ eye health by conducting various social contribution activities together with Korean Foundation for the Prevention of Blindness.
